Showing results (281-290 of 524) with videos related to
Sort By:
Pageof 53
International Journal of Molecular Sciences|July 9, 2022
The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver DamageChiara Rossi, Antonio Salvati, Mariarosaria Distaso, et al.Acta Diabetologica|May 29, 2021
All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of diseaseMassimiliano Copetti, Edoardo Biancalana, Andrea Fontana, et al.European Heart Journal|December 8, 2022
Prevention of cardiorenal damage: importance of albuminuriaLuis M Ruilope, Alberto Ortiz, Alejandro Lucia, et al.Journal of Hypertension|October 3, 2002
The Framingham prediction rule is not valid in a European population of treated hypertensive patientsSylvie Bastuji-Garin, Anne Deverly, Dominique Moyse, et al.Journal of Hypertension|June 15, 2007
Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trialLuis M Ruilope, Alberto Zanchetti, Stevo Julius, et al.Journal of Hypertension|February 1, 2002
Valsartan improves fibrinolytic balance in atherosclerotic rabbitsM Pilar Oubiña, Natalia de Las Heras, Sandra Vázquez-Pérez, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 22, 2013
Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from SpainManuel Gorostidi, Pantelis A Sarafidis, Alejandro de la Sierra, et al.Journal of the American Medical Directors Association|January 3, 2018
Frailty, Disability, and Ambulatory Blood Pressure in Older AdultsTeresa Gijón-Conde, Auxiliadora Graciani, Esther López-García, et al.Circulation. Cardiovascular Quality and Outcomes|January 22, 2015
Trends in hypertension control among the older population of Spain from 2000 to 2001 to 2008 to 2010: role of frequency and intensity of drug treatmentJosé R Banegas, Beatriz Navarro-Vidal, Luis M Ruilope, et al.American Journal of Hypertension|November 10, 2004
Beyond hypertension toward guidelines for cardiovascular risk reductionMassimo Volpe, Michael H Alderman, Curt D Furberg, et al.Pageof 53